Literature DB >> 21263914

Prophylaxis for infective endocarditis.

J D Gray.   

Abstract

Although antibiotic prophylaxis for patients at risk for bacterial endocarditis has never been scientifcally tested, it is now an accepted practice in medicine. Patients at risk include all individuals with prosthetic valves, congenital or rheumatic heart disease, previous endocarditis, idiopathic hypertrophic subaortic stenosis (IHSS), and mitral valve prolapse with a holosytolic murmur. Dental, upper respiratory tract, genitourinary and gastrointestinal procedures associated with bacteremia are reviewed. New antibiotic regimens utilizing oral agents for shorter periods have recently been published and are outlined here. Patients at high risk of endocarditis (especially those with prosthetic valves) should continue to receive prophylactic antibiotics by the parenteral route.

Entities:  

Year:  1987        PMID: 21263914      PMCID: PMC2218443     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

1.  Endocarditis: epidemiology, pathophysiology, management, and prophylaxis.

Authors:  J H Oikawa; D Kaye
Journal:  Cardiovasc Clin       Date:  1986

2.  Bacterial endocarditis prophylaxis--tradition or necessity?

Authors:  E L Kaplan
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

3.  Prophylaxis of infective endocarditis.

Authors:  N A Simmons; R A Cawson; C A Clarke; S J Eykyn; A M Geddes; W A Littler; D A McGowan; C M Oakley; D C Shanson
Journal:  Lancet       Date:  1986-05-31       Impact factor: 79.321

Review 4.  Gastrointestinal instrumentation, bacteraemia, and endocarditis.

Authors:  P J Shorvon; S J Eykyn; P B Cotton
Journal:  Gut       Date:  1983-11       Impact factor: 23.059

5.  Current issues in prevention of infective endocarditis.

Authors:  D T Durack
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

6.  A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse.

Authors:  J D Clemens; R I Horwitz; C C Jaffe; A R Feinstein; B F Stanton
Journal:  N Engl J Med       Date:  1982-09-23       Impact factor: 91.245

7.  Transient bacteremia and endocarditis prophylaxis. A review.

Authors:  E D Everett; J V Hirschmann
Journal:  Medicine (Baltimore)       Date:  1977-01       Impact factor: 1.889

8.  Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry.

Authors:  D T Durack; E L Kaplan; A L Bisno
Journal:  JAMA       Date:  1983-11-04       Impact factor: 56.272

Review 9.  Prophylaxis for infective endocarditis: an update.

Authors:  D Kaye
Journal:  Ann Intern Med       Date:  1986-03       Impact factor: 25.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.